ATE403421T1 - Verfahren zur hemmung des wachstums von antibiotikaresistenten bakterien durch verwendung von pentan-1,5-diol - Google Patents

Verfahren zur hemmung des wachstums von antibiotikaresistenten bakterien durch verwendung von pentan-1,5-diol

Info

Publication number
ATE403421T1
ATE403421T1 AT04749039T AT04749039T ATE403421T1 AT E403421 T1 ATE403421 T1 AT E403421T1 AT 04749039 T AT04749039 T AT 04749039T AT 04749039 T AT04749039 T AT 04749039T AT E403421 T1 ATE403421 T1 AT E403421T1
Authority
AT
Austria
Prior art keywords
pentane
diol
composition
resistant bacteria
inhibiting
Prior art date
Application number
AT04749039T
Other languages
English (en)
Inventor
Jan Faergemann
Thomas Hedner
Original Assignee
Ambria Dermatology Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambria Dermatology Ab filed Critical Ambria Dermatology Ab
Application granted granted Critical
Publication of ATE403421T1 publication Critical patent/ATE403421T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]
AT04749039T 2003-06-26 2004-06-23 Verfahren zur hemmung des wachstums von antibiotikaresistenten bakterien durch verwendung von pentan-1,5-diol ATE403421T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301862A SE0301862D0 (sv) 2003-06-26 2003-06-26 Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier

Publications (1)

Publication Number Publication Date
ATE403421T1 true ATE403421T1 (de) 2008-08-15

Family

ID=27656597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04749039T ATE403421T1 (de) 2003-06-26 2004-06-23 Verfahren zur hemmung des wachstums von antibiotikaresistenten bakterien durch verwendung von pentan-1,5-diol

Country Status (16)

Country Link
US (1) US7973080B2 (de)
EP (1) EP1635802B1 (de)
JP (1) JP4824553B2 (de)
KR (1) KR20060103817A (de)
CN (1) CN1812775B (de)
AT (1) ATE403421T1 (de)
AU (1) AU2004249102A1 (de)
BR (1) BRPI0411749A (de)
CA (1) CA2529287A1 (de)
DE (1) DE602004015597D1 (de)
DK (1) DK1635802T3 (de)
ES (1) ES2313038T3 (de)
PL (1) PL1635802T3 (de)
RU (1) RU2355392C9 (de)
SE (1) SE0301862D0 (de)
WO (1) WO2004112765A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2586815A1 (en) 2004-11-29 2006-06-01 Ambria Dermatology Ab A composition comprising at least 3 different diols
JP2009517152A (ja) * 2005-11-29 2009-04-30 アンブリア ダーマトロジー アーベー 消臭剤としてのペンタン−１，５−ジオールを含む組成の使用
SE533425C2 (sv) * 2008-07-07 2010-09-21 Ambria Dermatology Ab Antimikrobiell sammansättning
FR2940281B1 (fr) 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
CN103816165B (zh) * 2014-03-11 2019-03-01 北京德默高科医药技术有限公司 一种治疗痤疮的组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2086393T3 (es) * 1989-01-31 1996-07-01 Ciba Geigy Ag Composicion desinfectante y de limpieza.
US5369129A (en) * 1989-06-13 1994-11-29 Hydro Pharma Ab Preparation of topical treatment of infections caused by virus, bacteria and fungi
SE464060B (sv) * 1989-06-13 1991-03-04 Gunnar Swanbeck Anvaendning av pentandiol eller hexandiol foer framstaellning av ett medel foer behandling av infektioner orsakade av herpesvirus
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
US5370876A (en) * 1993-01-08 1994-12-06 Microbarriers Antimicrobial protective skin composition and method for protecting skin from body fluids
US5879690A (en) 1995-09-07 1999-03-09 Perricone; Nicholas V. Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
US6548074B1 (en) * 1999-07-22 2003-04-15 Elizabeth Arden Co., Division Of Conopco, Inc. Silicone elastomer emulsions stabilized with pentylene glycol
US6649176B1 (en) * 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US20020192273A1 (en) * 2001-06-15 2002-12-19 Teri Buseman Therapeutic patch useful for the treatment of hemorrhoids

Also Published As

Publication number Publication date
JP2007521265A (ja) 2007-08-02
CN1812775A (zh) 2006-08-02
RU2355392C9 (ru) 2009-07-27
EP1635802B1 (de) 2008-08-06
RU2005140049A (ru) 2006-07-27
WO2004112765A1 (en) 2004-12-29
DK1635802T3 (da) 2008-12-08
PL1635802T3 (pl) 2009-01-30
CN1812775B (zh) 2011-07-27
SE0301862D0 (sv) 2003-06-26
AU2004249102A1 (en) 2004-12-29
KR20060103817A (ko) 2006-10-04
RU2355392C2 (ru) 2009-05-20
US7973080B2 (en) 2011-07-05
DE602004015597D1 (de) 2008-09-18
BRPI0411749A (pt) 2006-08-08
ES2313038T3 (es) 2009-03-01
CA2529287A1 (en) 2004-12-29
EP1635802A1 (de) 2006-03-22
US20070020322A1 (en) 2007-01-25
JP4824553B2 (ja) 2011-11-30

Similar Documents

Publication Publication Date Title
MX2019015822A (es) Composiciones, metodos y usos para limpieza, desinfeccion y/o esterilizacion.
DE60311272D1 (de) Neue purin- oder pyrrolol(2,3-d)pyrimidin-2-carbonsäurenitrile zur behandlung von mit cysteinproteaseaktivität assoziierten krankheiten
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
DE60335560D1 (de) Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen
ATE482616T1 (de) Zusammensetzungen mit hoher antiviraler und antibakterieller wirkung
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
DE502006007963D1 (de) Verwendung von hydrophobinen zur schmutzabweisenden behandlung von harten oberflächen
ATE458057T1 (de) Varianten der faktor-vii- oder -viia-gla-domäne
NO20052520D0 (no) Nye sulfamider
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
BR0313628A (pt) Composições lìquidas de limpeza
BR0213072A (pt) Sabonete em barra
DE602005024546D1 (de) System zur bewertung des ph-werts und der pufferkapazität von feuchtigkeit enthaltenden reinigungsartikeln
RS52511B (en) MACHINE DISINFECTION OF ITEMS
DE60309719D1 (de) N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis
MX2009011821A (es) Formulaciones de aminoacido n-halogenado y metodo para limpieza y desinfeccion.
ATE403421T1 (de) Verfahren zur hemmung des wachstums von antibiotikaresistenten bakterien durch verwendung von pentan-1,5-diol
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
DE602004031039D1 (de) Viruzide wirkungen von einer zubereitung enthaltend cetylpyridiniumchlorid und zitronensäure
DE60130321D1 (de) Verfahren zum sterilisieren von gegenständen
MY144204A (en) Aquoues olanexidine solution, method of preparing the same, and disinfectant
ATE345135T1 (de) Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
DE602004029459D1 (de) Verbessertes reinigungsmittel
ATE373700T1 (de) Organopolysiloxane-enthaltende zusammensetzung, verfahren zu ihrer herstellung und deren verwendung
MA27364A1 (fr) Compositions contenant des principes actifs adoucissants specifiques

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties